RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R2033254 | Secukinumab | Secukinumab (Cosentyx) is a human monoclonal antibody designed for the treatment |
| R2033255 | Daratumumab | Daratumumab is a human monoclonal antibody that targets CD38, a cell surface pro |
| R2033256 | Atezolizumab | Atezolizumab is a selective humanized monoclonal IgG1 antibody against programme |
| R2033257 | Dulaglutide (LY2189265) | Dulaglutide is a novel glucagon-like peptide-1 agonist (GLP-1) biologic drug con |
| R2033258 | Tocilizumab | Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the in |
| R2033259 | Natalizumab | Natalizumab is a recombinant, humanized monoclonal antibody, binds to α4β1-integ |
| R2033260 | Pertuzumab | Pertuzumab, a humanized monoclonal antibody, is a HER2 dimerization inhibitor fo |
| R2033261 | Panitumumab | Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the in |
| R2033262 | Mepolizumab | Mepolizumab is a humanized IL-5 antagonist monoclonal antibody produced by recom |
| R2033263 | Alemtuzumab | Alemtuzumab is a humanized monoclonal antibody against CD52, an antigen found on |
| R2033264 | Efmoroctocog alfa | Efmoroctocog alfa is a fully recombinant factor VIII-Fc fusion protein (rFVIIIFc |
| R2053266 | ULK-101;ULK101 | ULK-101 is a potent and selective ULK1 inhibitor, with IC50 |
| R2053267 | EIDD-2801;EIDD2801 | EIDD-2801 is an orally bioavailable prodrug of the ribonucleoside analog EIDD-19 |
| R2053268 | OGG1 inhibitor O8;O8 OGG1 Inhibitor | OGG1 inhibitor O8 Synonyms: Benzo[b]thiophene-2-carboxylic acid, 3,4-dichloro-, |
| R2053269 | Triazavirin | Triazavirin is a nucleoside analogue of nucleic acid and an antiviral agent. Tri |
| R2053270 | NBQX(FG9202) | NBQX is a highly selective and competitive AMPA receptor antagonist. |
| R2053271 | NS6740 | Synonyms:(1,4-diaza-bicyclo[3.2.2]non-4-yl)-5-(3-trifluoromethylphenyl)-furan-2- |
| R2053272 | H-151;H151 | H-151 is a highly potent, selective and covalent antagonist of STING, reduces TB |
| R2053273 | A939572;A-939572 | A939572 is a potent, and orally bioavailable stearoyl-CoA desaturase1 (SCD1) inh |
| R2053274 | AMTB hydrochloride | Synonyms:N-(3-Aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)benzam |
| R2053275 | GSK-626616 | GSK-626616 is a potent, orally bioavailable inhibitor of DYRK3 (IC50=0.7 nM). GS |
| R2053276 | Ac4GlcNAcF3 | Synonyms:2-trifluoracetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-D-glucopyranose;Acet |
| R2053277 | BL-918(compound 33i) | BL-918 (compound 33i) is an orally active UNC-51-like kinase 1 (ULK1) activator |
| R2053278 | BRD6989 | BRD6989, an analog of the natural product cortistatin A (dCA), inhibits CDK8 and |
| R2053279 | CCG 58150;CCG-58150 | CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) pr |
